Adding Pembrolizumab to CRT Does Not Improve Outcomes in Head and Neck Cancer

Pembrolizumab plus chemoradiotherapy (CRT) appears no more effective than CRT alone in locally advanced head and neck squamous cell carcinoma.

Related Keywords

Belgium ,Brussels ,Bruxelles Capitale ,Jean Pascal Machiels ,Cliniques Universitaires Saint Luc ,Merck Sharp Dohme ,Merck Sharp ,